🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesEchocardiographic changes on GLP-1 — November 2025 Page 5

Echocardiographic changes on GLP-1 — November 2025

NeuroNate Sat, Mar 14, 2026 at 8:34 PM 29 replies 1,138 viewsPage 5 of 6
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Mar 16, 2026 at 7:20 AM#21
Dr.PathRoch said:
bri_stats said: ...we don't know the long-term effects of cardiovascular risk...

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Sending this to two other people who asked me the same thing last week.

Last edited: Mar 16, 2026 at 8:20 AM
16 14hyun_seoul, jim_asheville, matt_MKE and 13 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Mar 16, 2026 at 2:11 PM#22

Adding the clinical framing, because it changes how the question reads.

Senior perspective on cardiovascular risk: I'm 66 years old and started this journey skeptically. My internist recommended it after years of failed interventions.

8 months later: down 49 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

17 15ricardo_MIA, BrianDallas92, labquiet_amy and 14 others
Reply Quote Save Share Report
tommy_boulder
Member
234
1,123
Nov 2024
Boulder, CO
Mar 16, 2026 at 9:03 PM#23
CarlaRPh_TPA said:
Senior perspective on cardiovascular risk: I'm 66 years old and started this journey skeptically.

Can confirm. Same sequence, different timescale. Nothing to add that would improve it.

18 16robert_kc, dan_philly, MeganSA_TX and 15 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Mar 17, 2026 at 3:55 AM#24
CarlaRPh_TPA said:
Senior perspective on cardiovascular risk: I'm 66 years old and started this journey skeptically.
CarlaRPh_TPA said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

19 17amy_econ_NJ, bbq_ray_KC, oliver_london and 16 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Mar 17, 2026 at 10:47 AM#25
CarlaRPh_TPA said:
Senior perspective on cardiovascular risk: I'm 66 years old and started this journey skeptically.

Dizziness and cardiovascular risk: I was lightheaded for the first 3 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

Last edited: Mar 17, 2026 at 1:47 PM
20 18cory_ATX, lori_vegas, Dr.PulmRoch and 17 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register